Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1969 Jun;17(6):881-7.
doi: 10.1128/am.17.6.881-887.1969.

Antipseudomonal activity of alpha-sulfoaminopenicillins

Antipseudomonal activity of alpha-sulfoaminopenicillins

K E Price et al. Appl Microbiol. 1969 Jun.

Abstract

A series of penicillins characterized by the presence of a sulfoamino or a modified sulfoamino group in the side chain was subjected to in vitro antimicrobial screening tests. Although the most potent members of the series were less active than benzylpenicillin against gram-positive bacteria and comparably active against most gram-negative bacteria, they were, on the average, 8 to 16 times more effective against strains of Pseudomonas aeruginosa. In other comparative laboratory tests against P. aeruginosa, these compounds were about as active as carbenicillin and four to eight times more active than ampicillin. An examination of structure-activity relationships indicated that maximal potency was obtained with penicillins having an alpha-(aromatic or heteroaromatic)-alpha-sulfoaminoacetamido side chain. The compound with an alpha-phenyl group was comparable in activity to those having an alpha-(2- or 3-thienyl) group, whereas any modification in position or structure of the alpha-sulfoamino group reduced activity. Results of studies with a cell-free P. aeruginosa beta-lactamase suggest that the marked inhibitory effects of alpha-sulfoamino penicillins for P. aeruginosa can be attributed, at least in part, to their high degree of resistance to this enzyme. Some derivatives, however, had weak antipseudomonal activity, despite possessing a high degree of beta-lactamase resistance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br Med J. 1967 May 27;2(5551):535-7 - PubMed
    1. Lancet. 1967 Jun 17;1(7503):1289-93 - PubMed
    1. Br Med J. 1967 Jul 8;3(5557):79-82 - PubMed
    1. Curr Ther Res Clin Exp. 1967 Jun;9(6):283-7 - PubMed
    1. Nature. 1967 Jul 1;215(5096):25-30 - PubMed

MeSH terms

LinkOut - more resources